An organization as advanced as ChemImage makes news on many fronts, and within many industries. Feel free to browse the source news releases that launched a number of well-placed (well-received) stories in pharmaceutical, biomedical, anti-terror, and forensic journals and publications.
December 16, 2010
U.S. Army Identifies ChemImage for the 2011 Commercialization Pilot Program
PITTSBURGH, Dec. 16, 2010 — ChemImage Corporation is one of 25 companies recently identified to participate in the U.S. Army Small Business Innovation Research (SBIR) 2011 Commercialization Pilot Program (CPP) for its real-time chemometrics and sensor fusion (RTCSF) technology.
|
|
December 8, 2010
ChemImage Reports Advances
in Characterization of Untreated Fingerprints
PITTSBURGH, Dec. 8, 2010 — ChemImage Corporation recently reported results from a hyperspectral imaging (HSI) study that displayed a 42.8% overall improvement in characterization of untreated latent fingerprints in comparison to previous HSI image processing methods. |
|
October 14, 2010
ChemImage to Exhibit Breakthrough Hyperspectral Imaging Technology at
NEAFS Annual Meeting
PITTSBURGH, Oct. 14, 2010 — ChemImage Corporation will be exhibiting its breakthrough Hyperspectral Imaging (HSI) instrumentation at the 2010 Northeastern Association of Forensic Scientists (NEAFS) and New England Division of the International Association for Identification (NEDIAI) Joint Meeting, Nov. 8-12 at the Equinox Resort & Spa, Manchester, Vt.
|
|
September 28, 2010
ChemImage to Exhibit Breakthrough Technology at MAFS Annual Meeting
PITTSBURGH, Sept. 28, 2010 — ChemImage Corporation will be exhibiting its Hyperspectral Imaging (HSI) instrumentation at the Midwestern Association of Forensic Scientists (MAFS) 39th Annual Meeting, Oct. 4-8 at the Kansas City Marriott Downtown, Kansas City, Mo.
|
|
August 23, 2010
ChemImage Reaches Agreement with Light Ace HK LTD to Distribute the FALCON II System and Services in China
PITTSBURGH, Aug. 23, 2010 — ChemImage Corporation recently reached an agreement with Light Ace HK LTD, a China-based distributor of laboratory equipment, instrumentation and services, to offer the Falcon IITM Wide-Field Raman Chemical Imaging System and select analytical contract services in China.
|
|
August 17, 2010
ChemImage to Present Inkjet Discrimination
Research Results at the 6th EDEWG Conference
PITTSBURGH, Aug. 17, 2010 — ChemImage Corporation will be presenting research results on a new inkjet printer discrimination technique involving hyperspectral imaging (HSI) at the 6th EDEWG Conference, a meeting of the European Document Experts Working Group, in Dubrovnik, Croatia from Sept. 21-24.
|
|
August 12, 2010
ChemImage to Present a Hands-On Hyperspectral Imaging Workshop at the International Symposium on the Forensic Sciences in Sydney
PITTSBURGH, Aug. 12, 2010 — ChemImage Corporation will be instructing a workshop on the basic theories and methods associated with hyperspectral imaging (HSI) on Friday, Sept. 10 at the 20th International Symposium on the Forensic Sciences, a biennial meeting of the Australian New Zealand Forensic Science Society in Sydney, Australia. |
|
August 10, 2010
Prediction of Prostate Cancer Progression Possible with Hyperspectral Imaging
A study conducted by scientists at ChemImage Corporation, in partnership with a well-known U.S. medical research and treatment center, revealed that Raman Molecular Imaging (RMI), a type of hyperspectral imaging, has great potential in predicting the progression of prostate cancer. |
|
August 6, 2010
ChemImage to Hold a Session on Forensic Spectral Analysis at ASQDE Meeting
What is a spectrum? How is spectral information extracted from an image? Why is multivariate statistical analysis important? These issues and more will be addressed at a ChemImage-sponsored breakfast session at The 68th Annual General Meeting of the American Society of Questioned Document Examiners (ASQDE), Aug. 28-Sept. 2 in the Fairmont Empress Hotel, Victoria, British Columbia.
|
|
August 5, 2010
Hyperspectral Imaging Shows Promise in Solving Diagnostic Dilemmas in Pathology
Raman molecular imaging (RMI), a form of hyperspectral imaging, shows promise in identifying cancers that are typically difficult to diagnose. Its history, successes and current advancements will be discussed at the International Conference on Raman Spectroscopy (ICORS), Aug. 13 from 8:30 – 10:00 a.m. at the Boston Park Plaza Hotel in Boston. |
|
July 13, 2010
ChemImage Issued Patent for Diagnosis of Kidney Cancer
Scientists at ChemImage Corporation are one step closer to making objective diagnoses of renal disease tissue a reality today with the issuance of patent number 7,755,757. This patent describes a Raman molecular imaging (RMI) system and method for distinguishing renal oncocytoma, a benign diagnosis, from chromophobe renal carcinoma, a malignant diagnosis. |
|
May 17, 2010
ChemImage to Participate in the 37th Annual Meeting
and Exposition of the Controlled Release Society
ChemImage Corporation will be presenting and exhibiting at the 37th Annual Meeting and Exposition of the Controlled Release Society, an international gathering focused on the science and technologies behind the delivery of bioactive agents, July 10-14 at the Oregon Convention Center in Portland, Ore. |
|
May 3, 2010
Research Points to Raman Chemical Imaging as Means for Determining Drug Particle Size in Dry Powder Inhalers In Vitro
Recent research conducted by scientists at ChemImage Corporation revealed that wide-field Raman Chemical Imaging shows promise as an in vitro method for identifying drug particle size distribution of Advair Discus® 500/50, a commercial dry powder inhaler with two active pharmaceutical ingredients. |
|
April 6, 2010
ChemImage Issued 100th Patent
ChemImage Corporation announced today the receipt of its 100th U.S. patent, number 7,692,776 for a chemical imaging explosives optical sensor that detects explosive compounds. |
|
March 17, 2010
ChemImage’s Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product DevelopmenT
ChemImage, a world leader in chemical imaging products and services, will present the results of an ingredient-specific particle sizing (ISPS™) study on a combination Metered Dose Inhaler product at Respiratory Drug Delivery (RDD) 2010 (www.rddonline.com). |
| |